… Fukushi, DL Patton & JT Grayston: Demonstration of Chlamydia pneumoniae in
atherosclerotic lesions of coronary arteries. J Infect Dis 167, 841-849 (1993) 44. Kuo C.-c …

Objective. —To study the clinical characteristics of respiratory tract illness caused
byChlamydia pneumoniae. Design. —Prospective clinical, bacteriologic, and serologic study. …

… current evidence regarding macrolides for asthma (Hahn: personal observations). Pending
… who have read and understood the evidence (Hahn: personal communication). We offer a …

LEARNING OBJECTIVES: Reading this article will familiarize the reader with (1) the unique
chlamydial intracellular life cycle and the propensity for human chlamydial infections to …

Background. Patient engagement throughout research is a way to generate more relevant
patient-important research questions, methods and results with the ultimate aim of facilitating …

BACKGROUND: Chlamydia pneumoniae infection can cause acute respiratory illnesses (including
sinusitis, bronchitis, and pneumonia) that are sometimes associated with wheezing. …

Background: Macrolides have antimicrobial and anti-inflammatory properties that may be
useful in the treatment of chronic asthma. Methods: We performed a randomized, placebo-…

… Copyright: © 2006 Hahn et al. This is an open-access article distributed under the terms of
the … Hahn controlled all data in the study and had final responsibility for the decision to submit …

Background Several Chlamydia pneumoniae (Cp) biomarkers have been associated with
asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was …

… Although this final solution may offer a long-term resolution, because of the addi- tional
complexity, we must await the results from Gupta, Lucas, and Hahn 47 the clinical trials of the …